The landscape of dementia prognosis has developed substantially with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-centered assessments that will detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in understanding neurodegenerative disorders, they'v... https://patrickl431myh1.corpfinwiki.com/user